2023 Q3 Form 10-K Financial Statement

#000155479523000209 Filed on July 11, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q1 2023
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $50.00K -$1.750K $450.0K
YoY Change -69.81% -101.29% -72.88%
% of Gross Profit
Research & Development $0.00 $10.89K $10.00K
YoY Change 38.37% -97.31%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $52.46K $9.150K $457.5K
YoY Change -68.33% -93.61% -77.48%
Operating Profit -$52.46K -$457.5K
YoY Change -68.33% -77.48%
Interest Expense $39.15K -$36.24K $195.5K
YoY Change -45.96% -18.56% -65.4%
% of Operating Profit
Other Income/Expense, Net $12.38K -$916.3K -$1.293M
YoY Change -107.94% -7501.05% 194.63%
Pretax Income -$40.07K -$1.086M -$1.750M
YoY Change -87.54% 327.13% -29.15%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$40.07K -$1.086M -$1.750M
YoY Change -87.54% 327.13% -29.15%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 -$0.05 -$0.07
COMMON SHARES
Basic Shares Outstanding 24.69M shares 612.8M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q3 2023 Q1 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.00K $28.90K $28.90K
YoY Change -37.26% 38.15% 38.15%
Cash & Equivalents $8.030K $28.90K $28.90K
Short-Term Investments
Other Short-Term Assets $10.00K $7.980K $7.980K
YoY Change -88.89% -97.04% -97.04%
Inventory
Prepaid Expenses $7.980K
Receivables
Other Receivables
Total Short-Term Assets $16.01K $36.88K $36.88K
YoY Change -84.89% -87.32% -87.32%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $16.01K $36.88K $36.88K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $16.01K $36.88K $36.88K
YoY Change -84.89% -87.32% -87.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.500K $3.500K
YoY Change
Accrued Expenses $60.00K $29.39K $29.39K
YoY Change 10482.01% 636.41% 131.42%
Deferred Revenue
YoY Change
Short-Term Debt $160.0K $62.01K $62.01K
YoY Change 57.05% -41.09% -41.09%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $373.2K $183.1K $183.1K
YoY Change 80.36% -33.54% -33.54%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $373.2K $183.1K $183.1K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $373.2K $183.1K $183.1K
YoY Change 80.36% -33.54% -33.54%
SHAREHOLDERS EQUITY
Retained Earnings -$17.33M -$17.12M
YoY Change 9.08% 11.39%
Common Stock $24.69K $24.69K
YoY Change -95.95% -95.84%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$357.2K -$146.2K -$146.2K
YoY Change
Total Liabilities & Shareholders Equity $16.01K $36.88K $36.88K
YoY Change -84.89% -87.32% -87.32%

Cashflow Statement

Concept 2023 Q3 2023 Q1 2023
OPERATING ACTIVITIES
Net Income -$40.07K -$1.086M -$1.750M
YoY Change -87.54% 327.13% -29.15%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$50.00K -$26.62K -$142.0K
YoY Change -21.72% -34.43% -64.16%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 30.00K 30.00K 150.0K
YoY Change -40.0% -42.86% -49.15%
NET CHANGE
Cash From Operating Activities -50.00K -26.62K -142.0K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 30.00K 30.00K 150.0K
Net Change In Cash -20.00K 3.380K 7.980K
YoY Change 44.2% -71.6% -107.88%
FREE CASH FLOW
Cash From Operating Activities -$50.00K -$26.62K -$142.0K
Capital Expenditures $0.00 $0.00
Free Cash Flow -$26.62K -$142.0K
YoY Change -34.43% -64.16%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 us-gaap Professional Fees
ProfessionalFees
usd
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001570937
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
usd
CY2023 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2022 ATAO Common Stock Issued For Accounts Payable Related Party
CommonStockIssuedForAccountsPayableRelatedParty
usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17116525 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0044 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2023Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
333-190235
CY2023 dei Entity Registrant Name
EntityRegistrantName
ALTAIR INTERNATIONAL CORP.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
99-0385465
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
322 North Shore Drive
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Building 1B, Suite 200
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Pittsburgh
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
15212
CY2023 dei City Area Code
CityAreaCode
412
CY2023 dei Local Phone Number
LocalPhoneNumber
770-3140
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Public Float
EntityPublicFloat
8024044 usd
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
24692449 shares
CY2023 dei Auditor Firm
AuditorFirmId
5525
CY2023 dei Auditor Name
AuditorName
Fruci & Associates II, PLLC
CY2023 dei Auditor Location
AuditorLocation
Spokane, Washington
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28897 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20917 usd
CY2023Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
7980 usd
CY2022Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
270000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
36877 usd
CY2022Q1 us-gaap Assets Current
AssetsCurrent
290917 usd
CY2023Q1 us-gaap Assets
Assets
36877 usd
CY2022Q1 us-gaap Assets
Assets
290917 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3500 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
25500 usd
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4000 usd
CY2023Q1 us-gaap Loans Payable Current
LoansPayableCurrent
14165 usd
CY2022Q1 us-gaap Loans Payable Current
LoansPayableCurrent
49155 usd
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
3889 usd
CY2022Q1 us-gaap Interest Payable Current
InterestPayableCurrent
8701 usd
CY2023Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
47844 usd
CY2022Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
56103 usd
CY2023Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
88169 usd
CY2022Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
157507 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
183067 usd
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
275466 usd
CY2023Q1 us-gaap Liabilities
Liabilities
183067 usd
CY2022Q1 us-gaap Liabilities
Liabilities
275466 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24692449 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24692449 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23769668 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23769668 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
24693 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
23770 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
16945642 usd
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
15357857 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17116525 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15366176 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-146190 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
15451 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
36877 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
290917 usd
CY2023 us-gaap Exploration Expense
ExplorationExpense
10890 usd
CY2022 us-gaap Exploration Expense
ExplorationExpense
372195 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
1317862 usd
CY2023 us-gaap Labor And Related Expense
LaborAndRelatedExpense
318000 usd
CY2022 us-gaap Labor And Related Expense
LaborAndRelatedExpense
138000 usd
CY2023 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
32500 usd
CY2022 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
30000 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
96150 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
173669 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
457540 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
2031726 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-457540 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-2031726 usd
CY2023 us-gaap Interest Expense
InterestExpense
195528 usd
CY2022 us-gaap Interest Expense
InterestExpense
565067 usd
CY2022 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
107000 usd
CY2023 ATAO Gain Loss On Conversion Of Debt
GainLossOnConversionOfDebt
38444 usd
CY2022 ATAO Gain Loss On Conversion Of Debt
GainLossOnConversionOfDebt
3269 usd
CY2023 ATAO Change In Fair Value Other Expense
ChangeInFairValueOtherExpense
-1003598 usd
CY2022 ATAO Change In Fair Value Other Expense
ChangeInFairValueOtherExpense
455023 usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
6000 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5647 usd
CY2023 ATAO Loss On Issuance Of Convertible Debt
LossOnIssuanceOfConvertibleDebt
138127 usd
CY2022 ATAO Loss On Issuance Of Convertible Debt
LossOnIssuanceOfConvertibleDebt
219366 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1292809 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-438788 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-1750349 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-2470514 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-1750349 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-2470514 usd
CY2023 ATAO Earnings Per Share Basic And Diluted Atao
EarningsPerShareBasicAndDilutedATAO
-0.07
CY2022 ATAO Earnings Per Share Basic And Diluted Atao
EarningsPerShareBasicAndDilutedATAO
-0.11
CY2023 ATAO Weighted Average Number Of Shares Outstanding Basic And Diluted Atao
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedATAO
24234937 shares
CY2022 ATAO Weighted Average Number Of Shares Outstanding Basic And Diluted Atao
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedATAO
22910017 shares
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-379661 usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
890145 usd
CY2022 ATAO Stock Issued During Period Value Issued For Services1
StockIssuedDuringPeriodValueIssuedForServices1
1360481 usd
CY2022 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
600000 usd
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
15000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-2470514 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
15451 usd
CY2023 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1566208 usd
CY2023 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
22500 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-1750349 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-146190 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-1750349 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-2470514 usd
CY2023 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
184389 usd
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
529432 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
1536419 usd
CY2023 ATAO Stock Based Compensation Related Party
StockBasedCompensationRelatedParty
270000 usd
CY2022 ATAO Stock Based Compensation Related Party
StockBasedCompensationRelatedParty
90000 usd
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
107000 usd
CY2023 ATAO Gains Losses On Extinguishment Of Debt1
GainsLossesOnExtinguishmentOfDebt1
-38444 usd
CY2022 ATAO Gains Losses On Extinguishment Of Debt1
GainsLossesOnExtinguishmentOfDebt1
-3269 usd
CY2023 ATAO Gain Loss On Issuance Of Convertible Debt
GainLossOnIssuanceOfConvertibleDebt
138127 usd
CY2022 ATAO Gain Loss On Issuance Of Convertible Debt
GainLossOnIssuanceOfConvertibleDebt
219366 usd
CY2023 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
-6000 usd
CY2022 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
5647 usd
CY2023 us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
-1003598 usd
CY2022 us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
455023 usd
CY2023 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-7980 usd
CY2022 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
13000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-12000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3014 usd
CY2023 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
41500 usd
CY2022 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
4000 usd
CY2023 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-11139 usd
CY2022 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-30718 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-142020 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-396238 usd
CY2023 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
100000 usd
CY2022 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
520000 usd
CY2023 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
50000 usd
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
75000 usd
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
300000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
150000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
295000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7980 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-101238 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20917 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
122155 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28897 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20917 usd
CY2023 ATAO Common Stock Issued For Accounts Payable Related Party
CommonStockIssuedForAccountsPayableRelatedParty
22500 usd
CY2023 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
247364 usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
545079 usd
ATAO Royalty Amount Paid Maximum Annual Limit License Agreement
RoyaltyAmountPaidMaximumAnnualLimitLicenseAgreement
8000000 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_845_eus-gaap--UseOfEstimates_zrnBZIAWuQDc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_863_zPfc79Wnsoq8">Use of estimates</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates.</p>
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_847_eus-gaap--ConcentrationRiskCreditRisk_zaMFDOxMndRf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_86E_zy3pvl5sH92i">Concentrations of Credit Risk</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. We believe we are not exposed to any significant credit risk on cash.</p>
CY2021 ATAO Shares Issued Asset Purchase Agreement Price Per Share
SharesIssuedAssetPurchaseAgreementPricePerShare
4.50
CY2021 ATAO Noncash Expense Of Share Issuances
NoncashExpenseOfShareIssuances
450000 usd
CY2021 ATAO Company Shares Received By Cryptosolar
CompanySharesReceivedByCryptosolar
100000 shares
CY2021 ATAO Additional Shares To Be Issued To Cryptosolar
AdditionalSharesToBeIssuedToCryptosolar
36000 shares
CY2021 ATAO Net Profit Percentage To Be Paid To Crypto Solar
NetProfitPercentageToBePaidToCryptoSolar
0.20 pure
CY2022 ATAO Monthly Consulting Fee Paid
MonthlyConsultingFeePaid
4000 usd
CY2023 ATAO Payment For Settlement Of Consulting Agreement Termination
PaymentForSettlementOfConsultingAgreementTermination
10000 usd
CY2023 ATAO Gain On Settlement Of Consulting Agreement Termination
GainOnSettlementOfConsultingAgreementTermination
6000 usd
CY2021 ATAO Company Shares Received By Cryptosolar
CompanySharesReceivedByCryptosolar
100000 shares
CY2022 ATAO Company Shares Received By Cryptosolar
CompanySharesReceivedByCryptosolar
16000 shares
CY2022 ATAO Shares Issued Asset Purchase Agreement Price Per Share
SharesIssuedAssetPurchaseAgreementPricePerShare
2.00
CY2022 ATAO Noncash Expense Of Share Issuances
NoncashExpenseOfShareIssuances
32000 usd
CY2021 ATAO Noncash Expense Of Share Issuances Impairment
NoncashExpenseOfShareIssuancesImpairment
450000 usd
CY2022 ATAO Noncash Expense Of Share Issuances Impairment
NoncashExpenseOfShareIssuancesImpairment
32000 usd
CY2022Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
25000 usd
CY2023Q1 us-gaap Share Price
SharePrice
0.051
CY2022Q1 us-gaap Share Price
SharePrice
0.0255
CY2023 ATAO Conversion Price Minimum
ConversionPriceMinimum
0.015
CY2023 ATAO Conversion Price Maximum
ConversionPriceMaximum
0.056
CY2022 ATAO Conversion Price Maximum
ConversionPriceMaximum
0.0172
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
1.8753 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
2.0008 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
1.2288 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.4618 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0464 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0494 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0163 pure
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P0Y1M17D
CY2023 ATAO Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2
P0Y11M26D
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P0Y5M8D
CY2022 ATAO Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2
P0Y11M4D
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
0 usd
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3991 usd
CY2023Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 25
CY2023Q1 us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
500000000 shares
CY2023 ATAO Common Stock Reclassed To Additional Paid In Capital
CommonStockReclassedToAdditionalPaidInCapital
592619 usd
CY2021Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
40000 shares
CY2023Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.25
CY2023 ATAO Aggregate Fair Value Of Warrants
AggregateFairValueOfWarrants
180000 usd
CY2023Q1 ATAO Warrants Estimates Used Stock Price
WarrantsEstimatesUsedStockPrice
4.50
CY2023 ATAO Warrants Estimates Used Exercise Price
WarrantsEstimatesUsedExercisePrice
0.25
CY2023 ATAO Warrants Estimates Used Risk Free Rate
WarrantsEstimatesUsedRiskFreeRate
0.0157 pure
CY2023 ATAO Warrants Estimates Used Volatility
WarrantsEstimatesUsedVolatility
7.3546 pure
CY2023 us-gaap Officers Compensation
OfficersCompensation
34000 usd
CY2022 us-gaap Officers Compensation
OfficersCompensation
40000 usd
CY2023Q1 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
18000 usd
CY2022Q1 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
4000 usd
CY2022 ATAO Stock Issued During Period Shares Related Parties2
StockIssuedDuringPeriodSharesRelatedParties2
400000 shares
CY2022 ATAO Stock Issued During Period Price Per Share Related Parties2
StockIssuedDuringPeriodPricePerShareRelatedParties2
0.90
CY2022 ATAO Stock Issued Related Party Non Cash Stock Compensation Expense2
StockIssuedRelatedPartyNonCashStockCompensationExpense2
360000 usd
CY2023 ATAO Conversion Of Payables Into Common Stock Amount
ConversionOfPayablesIntoCommonStockAmount
22500 usd
CY2023 ATAO Conversion Of Payables Into Common Stock Shares
ConversionOfPayablesIntoCommonStockShares
70000 shares
CY2023Q1 ATAO Amounts Owed To Related Party For Director Fees
AmountsOwedToRelatedPartyForDirectorFees
7500 usd
CY2023 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
367600 usd
CY2022 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
503000 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
367600 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
503000 usd
CY2023Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3594000 usd
CY2022Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3211000 usd
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3594000 usd
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3211000 usd
CY2023Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
3594000 usd
CY2023Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
25000 usd
CY2023Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.08 pure

Files In Submission

Name View Source Status
0001554795-23-000209-index-headers.html Edgar Link pending
0001554795-23-000209-index.html Edgar Link pending
0001554795-23-000209.txt Edgar Link pending
0001554795-23-000209-xbrl.zip Edgar Link pending
atao-20230331.xsd Edgar Link pending
atao0629form10k.htm Edgar Link pending
atao0629form10kexh31_1.htm Edgar Link pending
atao0629form10kexh32_1.htm Edgar Link pending
atao-20230331_cal.xml Edgar Link unprocessable
atao-20230331_def.xml Edgar Link unprocessable
atao-20230331_lab.xml Edgar Link unprocessable
atao-20230331_pre.xml Edgar Link unprocessable
atao0629form10k_htm.xml Edgar Link completed
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
image_002.gif Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable